ArticleApplied microbiology and biotechnology2017
Smokeless tobacco products harbor diverse bacterial microbiota that differ across products and brands.
Article in Applied microbiology and biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Impact of sudanese chewing tobacco toombak on oral bacteria - a culture-based pilot study.Clinical oral investigations · 2026Article
- Viable, Multi-Drug-Resistant Bacteria Recovered from E-Liquids Used with Commercial Electronic Cigarettes.International journal of environmental research and public health · 2025Article
- The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis.Life (Basel, Switzerland) · 2025Review
- Bacterial community structure associated with smokeless tobacco reference products under different storage conditions and durations.Frontiers in public health · 2025Article
- 16S rDNA-Based Amplicon Analysis Unveiled a Correlation Between the Bacterial Diversity and Antibiotic Resistance Genes of Bacteriome of Commercial Smokeless Tobacco Products.Applied biochemistry and biotechnology · 2024Article
- Exploring the Microbial Diversity and Composition of Three Cigar Product Categories.Microbial ecology · 2024Article
- Smokeless Tobacco Harbors Bacteria Involved in Biofilm Formation as Well as Salt and Heavy Metal Tolerance Activity.Applied biochemistry and biotechnology · 2024Article
- An update on the formation in tobacco, toxicity and carcinogenicity of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Carcinogenesis · 2024Review
- Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users.Addiction science & clinical practice · 2023Article
- Conventional tobacco products harbor unique and heterogenous microbiomes.Environmental research · 2023Article
- Article
- Study on the correlation between the dominant microflora and the main flavor substances in the fermentation process of cigar tobacco leaves.Frontiers in microbiology · 2023Article
- What Can We Learn about the Bias of Microbiome Studies from Analyzing Data from Mock Communities?Genes · 2022Article
- Bacterial communities of hookah tobacco products are diverse and differ across brands and flavors.Applied microbiology and biotechnology · 2022Article
- The Correlation of Swedish Snus, Nicotine Pouches and Other Tobacco Products with Oral Mucosal Health and Salivary Biomarkers.Dentistry journal · 2022Article
- Comparative and analytical characterization of the oral bacteriome of smokeless tobacco users with oral squamous cell carcinoma.Applied microbiology and biotechnology · 2022Article
- Phyllosphere microbial community of cigar tobacco and its corresponding metabolites.Frontiers in microbiology · 2022Article
- Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff.PloS one · 2022Article
- Geographic and position-based variations in phyllospheric bacterial communities present on flue-cured tobacco.Applied microbiology and biotechnology · 2021Article
- Microorganisms: crucial players of smokeless tobacco for several health attributes.Applied microbiology and biotechnology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Smokeless tobacco products contain numerous chemical compounds, including known human carcinogens. Other smokeless tobacco constituents, including bacteria, may also contribute to adverse health effects among smokeless tobacco users. However, there is a lack of data regarding the microbial constituents of smokeless tobacco. Our goal was to characterize the bacterial microbiota of different smokeless tobacco products and evaluate differences across product types and brands. DNA was extracted from 15 brands of smokeless tobacco products (including dry snuff, moist snuff, snus, and Swedish snus) and 6 handmade products (e.g., toombak) using an enzymatic and mechanical lysis approach. Bacterial community profiling was performed using PCR amplification of the V1-V2 hypervariable region of the 16S rRNA gene, followed by 454 pyrosequencing of the resulting amplicons and sequence analysis using the QIIME package. Total viable counts were also determined to estimate the number of viable bacteria present in each product. Average total viable counts ranged from 0 to 9.35 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.